SUOX has shown great promise as a diagnostic and prognostic biomarker for various cancers, such as oral squamous cell carcinoma (Nakamura et al., 2018), and hepatocellular carcinoma (Jin et al., 2013). This evidence concerns the gene SUOX and hepatocellular carcinoma.